<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurotherapeutics</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotherapeutics</journal-id>
<journal-title-group>
<journal-title>Neurotherapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1933-7213</issn>
<issn pub-type="epub">1878-7479</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28497380</article-id>
<article-id pub-id-type="pmc">5509628</article-id>
<article-id pub-id-type="publisher-id">532</article-id>
<article-id pub-id-type="doi">10.1007/s13311-017-0532-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kabir</surname>
<given-names>Zeeba D.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martínez-Rivera</surname>
<given-names>Arlene</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rajadhyaksha</surname>
<given-names>Anjali M.</given-names>
</name>
<address>
<email>amr2011@med.cornell.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution>Pediatric Neurology, Pediatrics, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution>Weill Cornell Autism Research Program, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution>Feil Family Brain and Mind Research Institute, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<volume>14</volume>
<issue>3</issue>
<fpage>588</fpage>
<lpage>613</lpage>
<permissions>
<copyright-statement>© The American Society for Experimental NeuroTherapeutics, Inc. 2017</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">The L-type calcium channels (LTCCs) Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3, encoded by the <italic>CACNA1C</italic> and <italic>CACNA1D</italic> genes, respectively, are important regulators of calcium influx into cells and are critical for normal brain development and plasticity. In humans, <italic>CACNA1C</italic> has emerged as one of the most widely reproduced and prominent candidate risk genes for a range of neuropsychiatric disorders, including bipolar disorder (BD), schizophrenia (SCZ), major depressive disorder, autism spectrum disorder, and attention deficit hyperactivity disorder. Separately, <italic>CACNA1D</italic> has been found to be associated with BD and autism spectrum disorder, as well as cocaine dependence, a comorbid feature associated with psychiatric disorders. Despite growing evidence of a significant link between <italic>CACNA1C</italic> and <italic>CACNA1D</italic> and psychiatric disorders, our understanding of the biological mechanisms by which these LTCCs mediate neuropsychiatric-associated endophenotypes, many of which are shared across the different disorders, remains rudimentary. Clinical studies with LTCC blockers testing their efficacy to alleviate symptoms associated with BD, SCZ, and drug dependence have provided mixed results, underscoring the importance of further exploring the neurobiological consequences of dysregulated Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3. Here, we provide a review of clinical studies that have evaluated LTCC blockers for BD, SCZ, and drug dependence-associated symptoms, as well as rodent studies that have identified Ca<sub>v</sub>1.2- and Ca<sub>v</sub>1.3-specific molecular and cellular cascades that underlie mood (anxiety, depression), social behavior, cognition, and addiction.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1007/s13311-017-0532-0) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Ca<sub>v</sub>1.2</kwd>
<kwd>Ca<sub>v</sub>1.3</kwd>
<kwd>
<italic>CACNA1C</italic>
</kwd>
<kwd>
<italic>CACNA1D</italic>
</kwd>
<kwd>Mood</kwd>
<kwd>Social</kwd>
<kwd>Addiction</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The American Society for Experimental NeuroTherapeutics, Inc. 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>